Found: 7
Select item for more details and to access through your institution.
Corrigendum to "Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models".
- Published in:
- 2019
- By:
- Publication type:
- journal article
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00706-x
- By:
- Publication type:
- Article
Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8 + T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184512
- By:
- Publication type:
- Article
IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent Autophagy.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2861, doi. 10.3390/cancers14122861
- By:
- Publication type:
- Article
Bortezomib improves adoptive carbonic anhydrase IX-specific chimeric antigen receptor-modified NK92 cell therapy in mouse models of human renal cell carcinoma.
- Published in:
- Oncology Reports, 2018, v. 40, n. 6, p. 3714, doi. 10.3892/or.2018.6731
- By:
- Publication type:
- Article
Co‐immunization with L‐Myc enhances CD8<sup>+</sup> or CD103<sup>+</sup> DCs mediated tumor‐specific multi‐functional CD8<sup>+</sup> T cell responses.
- Published in:
- Cancer Science, 2021, v. 112, n. 9, p. 3469, doi. 10.1111/cas.15044
- By:
- Publication type:
- Article